First People's Hospital of Foshan Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Foshan China (1881)

Organization Overview

First Clinical Trial
2009
NCT01021566
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

First People's Hospital of Foshan

Active Ingredients

Drugs in Phase 4 Trials (10)

amoxicillin (1 trial)

bismuth (1 trial)

clarithromycin (biaxin) (1 trial)

esomeprazole (nexium) (1 trial)

infliximab (remicade) (1 trial)

interferon alpha-2b (Intron-A) (5 trials)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

sevoflurane (ultane) (1 trial)

vonoprazan (Voquezna) (1 trial)

Drugs in Phase 3 Trials (20)

bevacizumab (avastin) (1 trial)

camrelizumab (2 trials)

capecitabine (xeloda) (2 trials)

cisplatin (platinol) (11 trials)

dexamethasone (1 trial)

docetaxel (taxotere) (3 trials)

dydrogesterone (gynorest) (1 trial)

fluorouracil (efudex) (5 trials)

gemcitabine (gemzar) (3 trials)

lenvatinib (lenvima) (2 trials)

leucovorin (2 trials)

levoleucovorin (fusilev) (1 trial)

methadone (methadose) (1 trial)

nedaplatin (2 trials)

oxaliplatin (eloxatin) (2 trials)

pirarubicin (1 trial)

pomalidomide (pomalyst) (1 trial)

sintilimab (2 trials)

toripalimab (LOQTORZ) (2 trials)

ulinastatin (1 trial)

Drugs in Phase 2 Trials (11)

cd19 car-t cells (1 trial)

cetuximab (erbitux) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

endostatin (endostar) (1 trial)

etoposide (vepesid) (1 trial)

fludarabine (fludara) (1 trial)

lapatinib (tykerb) (1 trial)

nimotuzumab (1 trial)

paclitaxel (taxol) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

wharton's jelly mesenchymal stem cells (1 trial)

Drugs in Other Trials (4)

entecavir (baraclude) (1 trial)

interferon alpha-2a (roferon-a) (1 trial)

norepinephrine (levophed) (1 trial)

terlipressin (Terlivaz) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Behavior, Addictive (Phase 3)

Carcinoma (Phase 3)

Cardiomyopathies (Phase 2)

Cognitive Dysfunction (Phase 4)

Colorectal Neoplasms (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Infarction (Phase 2)

Ischemia (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Neoplasms (Phase 2)

Mucositis (Phase 3)

Myocardial Infarction (Phase 2)

Nasopharyngeal Carcinoma (Phase 3)

Nasopharyngeal Neoplasms (Phase 2)

Opioid-Related Disorders (Phase 3)

Peritoneal Neoplasms (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

ST Elevation Myocardial Infarction (Phase 2)

Stomatitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 37
  • # of Trial APIs: 45